Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07382349 · ClinicalTrials.gov registry record · NA
A Study of Electronic Clinical Decision Support Tools for Steatotic Liver Disease
A NA study, sponsored by Vanderbilt University Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 7,200
- Enrollment target
NCT07382349 is a NA study that has not yet begun recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 7,200 participants.
The verdict
NCT07382349, a NA study, has not yet begun recruiting, sponsored by Vanderbilt University Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 7,200 participants
- Enrollment target
Study Summary
The overall objectives of this study are to determine the effectiveness of a participant-specific guided electronic decision support system on provider decision making for participants with metabolic-dysfunction associated steatotic liver disease (MASLD), and to determine the acceptance and barriers for use of an electronic health record embedded algorithm for MASLD care management within ambulatory primary care, endocrinology, and general gastroenterology settings.
Interventions
- OTHER eMPOWER Decision Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,200 participants |
| Start Date | 2026-07 |
| Est. Completion | 2030-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07382349
The ClinicalTrials.gov registry entry for NCT07382349 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 7,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which eMPOWER Decision Aid is the first listed.
NCT07382349 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07382349 about?
NCT07382349 is a clinical study titled "A Study of Electronic Clinical Decision Support Tools for Steatotic Liver Disease". The overall objectives of this study are to determine the effectiveness of a participant-specific guided electronic decision support system on provider decision making for participants with metabolic-dysfunction associated steatotic liver disease (MASLD), and to determine the acceptance and barriers...
What is the current status of trial NCT07382349?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 7,200 participants. The study started on 2026-07. Estimated completion is 2030-02.
What interventions are being tested in trial NCT07382349?
The interventions under investigation include: eMPOWER Decision Aid (OTHER).
Who is sponsoring clinical trial NCT07382349?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.